Loading...
Explore Accretion Nutraveda SME IPO details, including IPO dates, financial statements, valuation, peer comparison and more.
Accretion Nutraveda is a manufacturer specializing in Ayurvedic and nutraceutical formulations. The company operates as a Contract Development and Manufacturing Organization (CDMO), offering a diverse range of dosage forms including tablets, capsules, syrups, powders, oils, and topical products.
Key highlights of Accretion Nutraveda include:
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
| Fields | Details |
|---|---|
| IPO Dates | 28 Jan - 30 Jan 2026 |
| IPO Price Band | ₹122 - ₹129 per share |
| Fresh Issue | 23.53 Cr |
| Offer For Sale | NIL |
| Total IPO Size | 23.53 Cr |
| Face Value | 10 |
| Listing On | BSE SME |
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
| Event | Date |
|---|---|
| IPO Opening Date | 28 Jan 2026 |
| IPO Closing Date | 30 Jan 2026 |
| Basis Of Allotment | 02 Feb 2026 |
| Refunds | 03 Feb 2026 |
| Demat Transfer | 03 Feb 2026 |
| IPO Listing Date | 04 Feb 2026 |
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
| Period Ended | 31 Mar 2023 | 31 Mar 2024 | 31 Mar 2025 | 30 Sep 2025 |
|---|---|---|---|---|
| Assets | 4.06 | 4.64 | 10.86 | 16.35 |
| Total Income | 3.07 | 5.20 | 16.06 | 14.07 |
| Profit After Tax | 0.28 | 0.82 | 2.61 | 2.33 |
| EBITDA | 0.59 | 1.21 | 3.65 | 3.29 |
| NET Worth | 0.26 | 1.08 | 5.35 | 8.26 |
| Reserves and Surplus | -0.10 | 0.72 | 4.86 | 2.95 |
| Total Borrowing | 1.97 | 2.17 | 3.86 | 4.43 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹cr)
Compare key financial metrics with industry peers to gain valuable insights into the company's performance compared to its competitors.
| Name | P/E | EPS | RoNW | NAV |
|---|---|---|---|---|
| Influx Healthtech | 46.99 | 4.81 | 11.1% | 38.98 |
| Walpar Nutritions | 3.3 | 1.06 | 6.24% | 17.05 |
| Accretion Nutraveda | 4.73 | 56.5% | 16.74 |
* Revenue in (₹cr), RoNW in (%), EPS, NAV in (₹). P/E ratio is based on the highest price from the IPO price band.
| Investor Type | Shares Offered |
|---|---|
| Qualified Institutional Buyer (QIB) | 9,08,000 (47.29%) |
| Non-Institutional Investor (NII/HNI) | 2,76,000 (14.37%) |
| Retail Individual Investor (RII) | 6,40,000 (33.33%) |
As the issue has not yet opened, subscription data is unavailable. However, you can view subscriptions for other ongoing issues here.
MUFG Intime India Private Limited (Formerly known as Link Intime India Private Limited)
Phone: + 91 810 811 4949
Email: ipo.helpdesk@linkintime.co.in
Website: https://linkintime.co.in/
Accretion Nutraveda Ltd.
27 Xcelon Industrial Park-1
Vasna-Chacharwadi,
TaSanand,
Ahmedabad, –382213
Website:http://www.accretionnutraveda.com/
Phone:+91- 9904366177
Email:compliance@accretionnutraveda.com